Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrine therapy for prostate cancer.

Jan-Erik Damber1

  • 1Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden. jan-erik.damber@urology.gu.se

Acta Oncologica (Stockholm, Sweden)
|September 17, 2005
PubMed
Summary

Endocrine therapy for prostate cancer, targeting androgenic effects, is increasingly explored as adjuvant treatment. Early hormonal intervention may offer survival benefits, with discussions on optimal timing and combination strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS.

Cancer medicine·2025
Same author

Magnetic Resonance Imaging as a Tool for Monitoring Intratibial Growth of Experimental Prostate Cancer Metastases in Mice.

Methods and protocols·2023
Same author

Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14).

Acta oncologica (Stockholm, Sweden)·2023
Same author

Osteoclasts directly influence castration-resistant prostate cancer cells.

Clinical & experimental metastasis·2022
Same author

Androgens, aging, and prostate health.

Reviews in endocrine & metabolic disorders·2022
Same author

Timing of the Pubertal Growth Spurt and Prostate Cancer.

Cancers·2021

Area of Science:

  • Oncology
  • Endocrinology
  • Urology

Background:

  • Endocrine therapy for prostate cancer primarily targets androgenic stimulation of tumor cells.
  • Current use is mainly for advanced stages, but early application is gaining interest.

Purpose of the Study:

  • To review the principles and evolving applications of endocrine therapy in prostate cancer management.
  • To discuss the potential benefits of early and adjuvant endocrine treatment, including timing and combination strategies.

Main Methods:

  • Overview of established endocrine treatment modalities for prostate cancer.
  • Discussion of GnRH agonists/antagonists, antiandrogens, and oestrogens.
  • Exploration of treatment timing, combined androgen blockade, and intermittent therapy.

Main Results:

  • Non-steroidal antiandrogens offer a side-effect profile favorable for adjuvant therapy compared to castration.
  • Early endocrine treatment may confer survival advantages in specific prostate cancer stages.
  • Optimal timing, combination therapy, and intermittent approaches are key considerations.

Conclusions:

  • Endocrine therapy is expanding beyond advanced prostate cancer, with potential as adjuvant treatment after localized therapies.
  • Further research into optimal timing and combination strategies is warranted to maximize survival benefits.
  • Non-steroidal antiandrogens represent a promising option for early and adjuvant endocrine management.

Related Experiment Videos